Chattem Sanofi Drug Patent Portfolio
Chattem Sanofi owns 11 orange book drugs protected by 34 US patents with Xyzal Allergy 24Hr having the least patent protection, holding only 1 patent. And Children'S Allegra Hives with maximum patent protection, holding 19 patents. Given below is the list of Chattem Sanofi's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8933097 | Fexofenadine suspension formulation | 02 Aug, 2030 | Active |
| US8633194 | Pharmaceutical composition of piperazine derivatives | 16 Oct, 2027 | Active |
| US6723348 | Orodispersible tablets containing fexofenadine | 26 Nov, 2021 | Expired |
| US8075911 | Transparent transdermal nicotine delivery devices | 22 May, 2021 | Expired |
| US6613357 | Osmotic device containing pseudoephedrine and an H1 antagonist | 25 Dec, 2020 | Expired |
| US8663680 | Transparent transdermal nicotine delivery devices | 13 Feb, 2020 | Expired |
| US8999379 | Transparent transdermal nicotine delivery devices | 13 Feb, 2020 | Expired |
| US9205059 | Transparent transdermal nicotine delivery devices | 15 Dec, 2019 | Expired |
| US6039974 | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | 31 Jul, 2018 | Expired |
| USRE39069 | Multi-layered osmotic device | 29 May, 2018 | Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient | 14 Sep, 2017 | Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient | 14 Mar, 2017 | Expired |
| US5976573 | Aqueous-based pharmaceutical composition | 03 Jul, 2016 | Expired |
| US6143329 | Aqueous-based pharmaceutical composition | 03 Jul, 2016 | Expired |
| US7977045 | Aqueous-based pharmaceutical composition | 03 Jul, 2016 | Expired |
| US5738872 | Pharmaceutical composition for piperidinoalkanol compounds | 28 Aug, 2015 | Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds | 28 Aug, 2015 | Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds | 28 Aug, 2015 | Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds | 28 Aug, 2015 | Expired |
| US5738872 | Pharmaceutical composition for piperidinoalkanol compounds | 28 Feb, 2015 | Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds | 28 Feb, 2015 | Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds | 28 Feb, 2015 | Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds | 28 Feb, 2015 | Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof | 18 Nov, 2014 | Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof | 18 Nov, 2014 | Expired |
| US5578610 | Piperidine derivatives | 26 May, 2014 | Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof | 18 May, 2014 | Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof | 18 May, 2014 | Expired |
| US5698558 | Methods for treating allergic disorders using optically pure (-) cetirizine | 26 Jan, 2014 | Expired |
| US5578610 | Piperidine derivatives | 26 Nov, 2013 | Expired |
| US5698558 | Methods for treating allergic disorders using optically pure (-) cetirizine | 26 Jul, 2013 | Expired |
| US5508038 | Polyisobutylene adhesives for transdermal devices | 16 Apr, 2013 | Expired |
| US6187791 | Method of providing an antihistaminic effect in a hepatically impaired patient | 11 Nov, 2012 | Expired |
| US6399632 | Method of providing an antihistaminic effect in a hepatically impaired patient | 11 Nov, 2012 | Expired |
Latest Legal Activities on Chattem Sanofi's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Chattem Sanofi.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 15 Jan, 2024 | US9205059 |
|
Expire Patent
Critical
| 15 Jan, 2024 | US8075911 |
|
Maintenance Fee Reminder Mailed
Critical
| 31 Jul, 2023 | US9205059 |
|
Maintenance Fee Reminder Mailed
Critical
| 31 Jul, 2023 | US8075911 |
|
Expire Patent
Critical
| 15 May, 2023 | US8999379 |
|
Maintenance Fee Reminder Mailed
Critical
| 28 Nov, 2022 | US8999379 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Jul, 2022 | US8933097 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Jul, 2022 | US8933097 |
|
Expire Patent
Critical
| 11 Apr, 2022 | US8663680 |
|
Maintenance Fee Reminder Mailed
Critical
| 25 Oct, 2021 | US8663680 |
| Review Certificate Mailed | 16 Aug, 2021 | US8633194 |
| Review Certificate | 22 Jul, 2021 | US8633194 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Jul, 2021 | US8633194 |
| Termination or Final Written Decision | 09 Jun, 2020 | US8633194 |
|
Expire Patent
Critical
| 19 Aug, 2019 | US7977045 |
Chattem Sanofi's Drug Patent Litigations
Chattem Sanofi's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 02, 1999, against patent number US6037353. The petitioner , challenged the validity of this patent, with YOUNG as the respondent. Click below to track the latest information on how companies are challenging Chattem Sanofi's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8633194 | December, 2018 |
Final Written Decision
(09 Jun, 2020)
| UCB Biopharma Sprl et al. | Apotex Inc. et al. |
| US8075911 | June, 2010 |
Decision
(25 May, 2011)
| Robert M. Gale | |
| US6037353 | November, 1999 |
Decision
(02 Nov, 1999)
| YOUNG | |
Chattem Sanofi Drug Patents' Oppositions Filed in EPO
Chattem Sanofi drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 23, 2010, by Zentiva K.S.. This opposition was filed on patent number EP05758582A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP05758582A | Jun, 2010 | Zentiva k.s. | Revoked |
Chattem Sanofi's Family Patents
Chattem Sanofi Drug List
Given below is the complete list of Chattem Sanofi's drugs and the patents protecting them.
1. Allegra
Allegra is protected by 18 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US5738872
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5855912
(Pediatric)
| Pharmaceutical compositions for piperidinalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5932247
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US6113942
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US7135571
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra's drug page
2. Allegra Allergy
Allegra Allergy is protected by 16 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US5855912
(Pediatric)
| Pharmaceutical compositions for piperidinalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5932247
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US6113942
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US7135571
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra Allergy's drug page
3. Allegra-d 12 Hour Allergy And Congestion
Allegra-d 12 Hour Allergy And Congestion is protected by 15 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6039974 | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
31 Jul, 2018
(6 years ago)
| Expired |
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US5855912
(Pediatric)
| Pharmaceutical compositions for piperidinalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US6113942
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US7135571
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra-d 12 Hour Allergy And Congestion's drug page
4. Allegra-d 24 Hour Allergy And Congestion
Allegra-d 24 Hour Allergy And Congestion is protected by 10 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6613357 | Osmotic device containing pseudoephedrine and an H1 antagonist |
25 Dec, 2020
(3 years ago)
| Expired |
| USRE39069 | Multi-layered osmotic device |
29 May, 2018
(6 years ago)
| Expired |
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra-d 24 Hour Allergy And Congestion's drug page
5. Allegra Hives
Allegra Hives is protected by 16 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US5855912
(Pediatric)
| Pharmaceutical compositions for piperidinalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5932247
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US6113942
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US7135571
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Allegra Hives's drug page
Explore Our Curated Drug Screens
6. Children's Allegra Allergy
Children's Allegra Allergy is protected by 19 patents, out of which 18 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8933097 | Fexofenadine suspension formulation |
02 Aug, 2030
(5 years from now)
| Active |
| US6723348 | Orodispersible tablets containing fexofenadine |
26 Nov, 2021
(3 years ago)
| Expired |
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US5855912
(Pediatric)
| Pharmaceutical compositions for piperidinalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5932247
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US6113942
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US7135571
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Allegra Allergy's drug page
7. Children's Allegra Hives
Children's Allegra Hives is protected by 19 patents, out of which 18 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8933097 | Fexofenadine suspension formulation |
02 Aug, 2030
(5 years from now)
| Active |
| US6723348 | Orodispersible tablets containing fexofenadine |
26 Nov, 2021
(3 years ago)
| Expired |
| US6037353
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Sep, 2017
(7 years ago)
| Expired |
| US6037353 | Method of providing an antihistaminic effect in a hepatically impaired patient |
14 Mar, 2017
(7 years ago)
| Expired |
| US5855912
(Pediatric)
| Pharmaceutical compositions for piperidinalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5932247
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US6113942
(Pediatric)
| Pharmaceutical composition for piperidinoalkanol compounds |
28 Aug, 2015
(9 years ago)
| Expired |
| US5738872 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5855912 | Pharmaceutical compositions for piperidinalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US5932247 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US6113942 | Pharmaceutical composition for piperidinoalkanol compounds |
28 Feb, 2015
(9 years ago)
| Expired |
| US7135571
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US7138524
(Pediatric)
| Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 Nov, 2014
(10 years ago)
| Expired |
| US5578610
(Pediatric)
| Piperidine derivatives |
26 May, 2014
(10 years ago)
| Expired |
| US7135571 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US7138524 | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
18 May, 2014
(10 years ago)
| Expired |
| US5578610 | Piperidine derivatives |
26 Nov, 2013
(11 years ago)
| Expired |
| US6187791
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
| US6399632
(Pediatric)
| Method of providing an antihistaminic effect in a hepatically impaired patient |
11 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Allegra Hives's drug page
8. Nasacort Allergy 24 Hour
Nasacort Allergy 24 Hour is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5976573 | Aqueous-based pharmaceutical composition |
03 Jul, 2016
(8 years ago)
| Expired |
| US6143329 | Aqueous-based pharmaceutical composition |
03 Jul, 2016
(8 years ago)
| Expired |
| US7977045 | Aqueous-based pharmaceutical composition |
03 Jul, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nasacort Allergy 24 Hour's drug page
9. Nicoderm Cq
Nicoderm Cq is protected by 5 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8075911 | Transparent transdermal nicotine delivery devices |
22 May, 2021
(3 years ago)
| Expired |
| US8663680 | Transparent transdermal nicotine delivery devices |
13 Feb, 2020
(4 years ago)
| Expired |
| US8999379 | Transparent transdermal nicotine delivery devices |
13 Feb, 2020
(4 years ago)
| Expired |
| US9205059 | Transparent transdermal nicotine delivery devices |
15 Dec, 2019
(5 years ago)
| Expired |
| US5508038 | Polyisobutylene adhesives for transdermal devices |
16 Apr, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nicoderm Cq's drug page
10. Xyzal
Xyzal is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5698558
(Pediatric)
| Methods for treating allergic disorders using optically pure (-) cetirizine |
26 Jan, 2014
(10 years ago)
| Expired |
| US5698558 | Methods for treating allergic disorders using optically pure (-) cetirizine |
26 Jul, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyzal's drug page
11. Xyzal Allergy 24hr
Xyzal Allergy 24hr is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8633194 | Pharmaceutical composition of piperazine derivatives |
16 Oct, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xyzal Allergy 24hr's drug page